Apolipoprotein A-I: Clinical Trials

1 trial of Apolipoprotein A-I, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Apolipoprotein A-I: new trials by email Literature Review of Apolipoprotein A-I trials Research Report on Apolipoprotein A-I

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
Apolipoprotein A-I [human] (apoA-I), Placebo - Acute Coronary Syndrome
Phase 3CompletedCSL Behring182262018-03-212025-01-14

Conditions studied

Acute Coronary Syndrome (1)  ·  Atherosclerosis (1)  ·  Atrial Fibrillation (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Heart Valve Diseases (1)  ·  Hemorrhagic Stroke (1)  ·  Hypertension (1)  ·  Ischemic Stroke (1)  ·  Peripheral Arterial Disease (1)  ·  Stroke (1)

Sponsors

CSL Behring (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Finland (1)  ·  France (1)

Top investigators

Danielle Duffy, MD (1)

Results publications

PMID 39221651, PMID 39230545

NIH funding

2017 (1)